The verified answer
As of Sep 2026, DEPLOY verifies Paradromics: 1 model, 2 deployments across 2 regions, $33.0M raised. 1 source back the record.
CategoryBiometric wearables
Overview
Paradromics is an Austin-based neurotechnology company developing the Connexus BCI, a high data-rate fully implantable brain-computer interface for restoring speech and computer control in people with severe motor impairment. First human implantation completed June 2026 at University of Michigan Health as part of the FDA-approved Connect-One clinical trial.
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- None on file
Valuation of record
DEPLOY VERIFIEDPriced roundSeries A post-money
Key facts
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Paradromics on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jun 2024. Explore where Paradromics's robots are operating, by place and type.
View the full Paradromics deployment record →
Relationships
Current leadership (1)
- Matt Angle CEO & Foundersecondary-verified
Founders (1)
- Matt Anglesolefounded 2015-01-01
Safety record
No incidents on record for Paradromics.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- Paradromics2 deployments
Recent coverage
Paradromics in third-party press
Peers
3 peers across 1 segment. Every Paradromics competitor derived from shared form-factor and application-domain edges.
bci(3)
3 companies in this segment · highly_concentrated (HHI 3365.5523463639224) · leader Blackrock Neurotech at 3565%
- Blackrock Neurotechdirect competitor(inferred)strong
- Precision Neurosciencedirect competitor(inferred)strong
- Synchrondirect competitor(inferred)strong
Financial state
- Total funding
- $33.0M
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- growth
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series A2023-05-18
$33M(reported) · $198M post
Timeline
Every recorded move in Paradromics’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundSeries A funding round
2023-05-18Series A raising $33000000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
Connexus BCI at United States (multiple hotel chains)
- Deployment verifiedVerifiedJun 1, 2024
Connexus BCI at Germany, Europe
Sources (1)
Common questions
What is Paradromics?
What does Paradromics make?
Is Paradromics publicly traded?
Who competes with Paradromics?
Who is the CEO of Paradromics?
How can I invest in Paradromics?
Where is Paradromics headquartered?
How much funding has Paradromics raised?
Who owns Paradromics?
Where does Paradromics operate robots?
How many robots has Paradromics deployed?
Is Paradromics a top robotics company?
Is Paradromics safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Paradromics.Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
In the press
Recent coverage mentioning Paradromics from third-party publications. Automatically surfaced; not part of the verified registry record.
Paradromics and University of Michigan complete first Connexus BCI implantation in clinical study
Paradromics has announced the completion of the first surgical implantation of its Connexus brain-computer interface (BCI) in the US Food and Drug Administration (FDA)-approved…
Paradromics Completes First Connexus BCI Human Implant
First human Connexus BCI implantation at University of Michigan; Connect-One trial at U-Michigan, UC Davis, Mass General Hospital
Machine-readable surfaces
- Markdown mirror: /companies/paradromics.md
- RSS feed: /companies/paradromics/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/c5bc5b03-fac1-4555-a5aa-70a2428f26b5
- Revision history: /companies/paradromics/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Google21 models
- Samsung Electronics4 models
- Butterfly Network2 models
- Abbott1 model
- Apple1 model
- Blackrock Neurotech1 model
Video
For those trapped within their own bodies by severe paralysis, a Texas-based company offers a new glimmer of hope. In a groundbreaking procedure, Austin's Paradromics has successfully completed the first human test of it
Paradromics builds brain-computer interface (BCI) technologies for seamless human-technology integration, restoring and enhancing human capabilities. https://w
Vivek Garipalli (Wormhole Capital) talks with Matt Angle (CEO, Paradromics) about Brain-Computer Interfaces (BCIs). BCIs are essentially a modem for the brain
Paradromics builds brain-computer interface (BCI) technologies for seamless human-technology integration, restoring and enhancing human capabilities. https://w
Biorobotics guided by brain-computer interfaces could give people with severe paralysis, including quadriplegics and ALS patients, the ability to stand, walk, a
Paradromics builds brain-computer interface (BCI) technologies for seamless human-technology integration, restoring and enhancing human capabilities. https://w
Vivek Garipalli (Wormhole Capital) talks with Matt Angle (CEO, Paradromics) about the revolutionary potential of Brain-Computer Interfaces (BCIs). Discover ho
An exoskeleton needs to stand on its own mechanically and function cleanly before it is ready for BCI control. Once it reaches that level, the BCI signals we ha
Extended info: News# 42431 Source: cnbc.com Publication: 18th of May 2023 News Source Crawler: digests, updates and bulletins from reliable sources to keep the
#CapCut I made this amazing video with CapCut. Open the link to try it out: capcut.com/tools/desktop-video-editor
Heat Index
Serious53/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Paradromics draws attention at the 15th percentile but verifies reality at the 52nd percentile among biometric robots. Hype Gap -36.7, 24th widest among biometric robots.
6-month trend
Analysis
Clean safety record across 2 verified deployments. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 23, 2026